Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294007 · ClinicalTrials.gov registry record · NA
Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
A NA study, sponsored by Alphatec Spine.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01294007 is a NA study that was terminated before completion, run by Alphatec Spine. The registered enrollment target is 1 participants.
The verdict
NCT01294007, a NA study, was terminated before completion, sponsored by Alphatec Spine.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the rate and quality of fusion of PureGen Osteoprogenitor Cell Allograft, compared to autograft bone in instrumented posterolateral fusion (PLF) procedures.
Interventions
- BIOLOGICAL PureGen Osteoprogenitor Cell Allograft
- PROCEDURE Autograft bone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01294007
The ClinicalTrials.gov registry entry for NCT01294007 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alphatec Spine, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PureGen Osteoprogenitor Cell Allograft is the first listed.
NCT01294007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01294007 about?
NCT01294007 is a clinical study titled "Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)". The purpose of this study is to evaluate the rate and quality of fusion of PureGen Osteoprogenitor Cell Allograft, compared to autograft bone in instrumented posterolateral fusion (PLF) procedures.
What is the current status of trial NCT01294007?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2011-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01294007?
The interventions under investigation include: PureGen Osteoprogenitor Cell Allograft (BIOLOGICAL), Autograft bone (PROCEDURE).
Who is sponsoring clinical trial NCT01294007?
This trial is sponsored by Alphatec Spine, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.